Pharma Research

Our comprehensive portfolio includes psychometrically validated clinical outcome assessments (COAs) that measure change in a variety of areas and symptoms. See how our assessments are being utilized in today’s clinical research. 

Growth Scale Values (GSVs)

Doctor examining microscope slides on a computer screen.

Using GSVs in clinical trials 

Learn more about development, interpretation, and out-of-level testing with GSVs in the latest technical report Growth Scale Value (GSV): Theory, Development, and Applications.

Download the report 

Pharma Research Services

Published Research:  

Review the published research spanning numerous diverse clinical areas. 

Pharma Blogs

  • Taking an innovative approach to challenging COA translations

    A graphic map of Europe with Estonia, Finland, and Hungary highlighted

    Over the last ten years, the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-3), a leading developmental assessment for children ages 1–42 months, has been referenced as an endpoint in 145 clinical trials (Citeline, 2024). Of those, 6.21% have included sites in the Finno-Ugric countries of Estonia, Finland, and Hungary.

    read more

  • Clinical trial considerations: All scores are not created equal

    genetic engineer working with analysis dna software on laptop in the genetic laboratory

    Dr. Lynsey Psimas, Ph.D and Dr. Paul Williams PsyD attended CNS Summit 2023 and were fortunate to have the opportunity to present their poster, Precision Matters: An Analysis on How Various Scores Behave When Measuring Change Over Time; Factors That Inform Score Selection for the Best Results”.

    read more